Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-20

Clinical Trial Update: HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating bioequivalence of infant versus standard ivermectin formulations in healthy adults for scabies. The trial status is suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVERMECTIN (Ivermectin)

Snippet

Sponsor: Murdoch Childrens Research Institute | Conditions: Scabies | Phase 1 | Status: SUSPENDED